![Photo](/media/story/19574/thumbnail-01-00197107-004.jpg)
News • Discovery
‘Hijacker’ drives cancer in some patients with high-risk neuroblastoma
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome “hijacks” DNA that regulates other genes. The resulting insights may help scientists develop more effective therapies, including precision medicines. The research involved investigators at St. Jude Children’s Research Hospital;…